Category Archives: pharmaceutical sales

Why a Ban on Rx DTC Advertising Makes Me Uncomfortable

And why digital health will eventually make the ban irrelevant By Peggy Salvatore This is the¬†fourth in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. I vaguely … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment

Meaningful Use Demise Opens Door to Truly Meaningful Health Tech Advances

By Peggy Salvatore MBA ¬† This is the third in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. Ding. Dong. MU is dead. The pivot by CMS … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare change management, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment

How a Digital Strategy can Help Healthcare Solve the Triple Aim

By Peggy Salvatore MBA I am writing this in possibly the biggest week for health tech junkies all year. Last week, the Consumer Electronics Show (now simply known as CES) rolled out acres of new tech toys, many of them … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | 2 Comments

Join us at ePharma Summit 2016 in New York City Next Month

By Peggy Salvatore MBA For the next two months, Health System Ed will be blogging about the ePharma Summit 2016 that will be held in NYC from February 29 to March2. Check out the conference details here. With my background … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | Leave a comment